<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 7 Issue 4</issue_number>
<issue_period>2016 (October - December)</issue_period>
<title><b>Evaluation of anti-diabetic activity of commercially available extracts of <i>phyllanthus emblica</i> in streptozocin induced diabetic rats</b></title>
<abstract> lessThan i greaterThan Phyllanthus emblica (syn. Emblica officinalis lessThan /i greaterThan ) or amla, is supposed to rejuvenate all the organ systems of the body, provide strength and wellness. It keeps us away from all the diseases by boosting our immune system. Besides,  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  plant is reported to possess many pharmacological and clinical properties.Objective: To evaluate the anti- diabetic activity of commercially available extracts  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  on high fat diet and low dose streptozocin induced diabetic rats.Materials and Methods: Diabetes was induced in albino rats using streptozocin 35 mg/kg i.p after giving high fat diet for 2 weeks. Animals with fasting blood glucose (FBG) above 200 mg/dl one week after injecting streptozocin were randomly divided into four groups of six rats each. Group 1- Diabetic rats, received only the distilled water (control),Group 2 - Diabetic rats, received  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  crude extract (200 mg/kg/day)–  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  Low dose (PEL), Group 3– Diabetic rats, received  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  crude extract (400 mg/kg/day) –  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  High dose (PEH), Group 4– Diabetic rats, received Glibenclamide (0.6 mg/kg/day) - Standard (S). All the animals received the respective drugs for six weeks. FBG was measured every 2 weeks till the end of sixth weeks by glucose-oxidase method.Results: Commercially available extracts  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  showed significant fall in fasting blood glucose (P lessThan  0.001) from second week onwards in comparison to diabetic control group.Conclusion: The results suggest that commercially available extracts  lessThan i greaterThan Phyllanthus emblica lessThan /i greaterThan  have significant hypoglycemic activity in diabetic model.</abstract>
<authors>NISHANT PATHAK, GYANENDRA KUMAR AND RAKESH CHANDRA CHAURASIA</authors>
<keywords>Diabetes Mellitus, Emblica Officinalis, Fasting Blood Glucose, Madhumeha, Indian Gooseberry, Maharog</keywords>
<pages>139-145</pages>
</article>
</Journal>
